Sildenafil Citrate

枸橼酸西地那非

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameSildenafil Citrate
Drug Alias Name威而刚Sildenafil wafersildenafilo酸盐枸橼酸西地那非昔多芬 +[31] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Becker muscular dystrophySexual Dysfunctions, Psychological +[79] 
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaErectile Dysfunction
Original Approved Country/TerritoryUnited States
Original Approved Date1998/03/27
Country/TerritoryCzechiaBelgiumCanada +[43] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityAugusta UniversityPfizer Upjohn Hong Kong Ltd +[25] 
Inactive CompaniesSeoul Pharma Co LtdHanmi Pharmaceutical Co LtdDana-Farber Cancer Institute +[47] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)DysmenorrheaHemolysis +[29] 
Inactive IndicationsBecker muscular dystrophySexual Dysfunctions, PsychologicalSmoking Cessation +[50] 

Other Information

ATC CodeG04BE03
Related LinksWikipediaDrugBankKEGG